AngioDynamics Reports Record Fiscal Year 2026 Fourth Quarter and Full Year Financial Results; Continued Execution Drives Med Tech Growth and Full-Year Profitability
Go back to AngioDynamics Reports Record Fiscal Year 2026 Fourth Quarter and Full Year Financial Results; Continued Execution Drives Med Tech Growth and Full-Year Profitability| AngioDynamics, Inc. (NASDAQ: ANGO) | Delayed: 15.37 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $15.37 | 52 Week High | $17.64 | |||
| Open | $15.55 | 52 Week Low | $9.71 | |||
| Day High | $15.62 | P/E | N/A | |||
| Day Low | $15.32 | EPS | $-0.07 | |||
| Volume | 558,682 | |||||
